Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2014 1
2016 3
2017 2
2019 2
2020 7
2021 6
2022 2
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
[2021 Oncology update].
Meyer ML, Chrysou K, Stamatiou A, Gilabert M, Herrera Gomez RG, Latifyan S, Masmoudi S, Mederos N, Perrinjaquet C, Berthold D, Bouchaab H, Cristina V, Digklia A, Michielin O, Orcurto A, Sarivalasis A, Stravodimou A, Wagner AD, Zaman K, Peters S, Jankovic J. Meyer ML, et al. Among authors: latifyan s. Rev Med Suisse. 2022 Feb 2;18(767):182-186. doi: 10.53738/REVMED.2022.18.767.182. Rev Med Suisse. 2022. PMID: 35107893 French.
Physical approaches to treat glioblastoma.
Latifyan S, de Micheli R, Hottinger AF. Latifyan S, et al. Curr Opin Oncol. 2020 Nov;32(6):640-649. doi: 10.1097/CCO.0000000000000689. Curr Opin Oncol. 2020. PMID: 32925205 Review.
[Oncology: what's new in 2022].
Nguyen-Ngoc T, Abdelhamid K, Degrauwe N, Galland S, Serena A, Christofis M, Mederos N, Bouchaab H, Diciolla A, Dris N, Orcurto A, Perrinjaquet C, Schnetz M, Latifyan S, Wetterwald L, Herrera Gómez RG, Cristina V, Sarivalasis A, Michielin O, Berthold D, Digklia A, Wagner AD, Zaman K, Peters S, Stravodimou A. Nguyen-Ngoc T, et al. Among authors: latifyan s. Rev Med Suisse. 2023 Jan 18;19(N° 809-10):52-57. doi: 10.53738/REVMED.2023.19.809-10.52. Rev Med Suisse. 2023. PMID: 36660838 French.
[Oncology: what's new in 2023].
Jankovic J, Abdelhamid K, Berthold D, Desbaillets N, Bouchaab H, Dei Tos G, Demicheli R, Diciolla A, Digklia A, Ferraro DA, Florez L, Galli-Vareia I, Hottinger A, Latifyan S, Liapi A, Mederos N, Giacomuzzi Moore B, Sakr R, Stamatiou A, Wagner AD, Peters S, Sarivalasis A, Vanniere F, Zaman K, Stravodimou A. Jankovic J, et al. Among authors: latifyan s. Rev Med Suisse. 2024 Jan 17;20(856-7):80-87. doi: 10.53738/REVMED.2024.20.856-7.80. Rev Med Suisse. 2024. PMID: 38231107 French.
[Locally advanced and metastatic melanoma : novelties].
Huber A, Latifyan S, Nikolopoulou A, Homicsko K, Berthod G, Michielin O, Özdemir BC. Huber A, et al. Among authors: latifyan s. Rev Med Suisse. 2020 May 27;16(695):1092-1097. Rev Med Suisse. 2020. PMID: 32462837 Review. French.
[Immunotherapy for bladder cancer in 2021].
Cisarovsky C, Latifyan S, Perrinjaquet C, Berthold D, Orcurto A. Cisarovsky C, et al. Among authors: latifyan s. Rev Med Suisse. 2021 May 19;17(739):974-977. Rev Med Suisse. 2021. PMID: 34009756 French.
[Advances in Oncology 2019].
Vernadou A, Ferahta N, Mederos N, Ferraro D, Dischl-Antonioni I, Diciolla A, Liapi A, Mosimann V, Latifyan S, Aedo-Lopez V, Berthold D, Digklia A, Michielin O, Montemurro M, Wagner AD, Zaman K, Peters S, Stravodimou A, Sarivalasis A. Vernadou A, et al. Among authors: latifyan s. Rev Med Suisse. 2020 Jan 15;16(676-7):72-77. Rev Med Suisse. 2020. PMID: 31961089 Review. French.
Modeling tumor size dynamics based on real-world electronic health records and image data in advanced melanoma patients receiving immunotherapy.
Courlet P, Abler D, Guidi M, Girard P, Amato F, Vietti Violi N, Dietz M, Guignard N, Wicky A, Latifyan S, De Micheli R, Jreige M, Dromain C, Csajka C, Prior JO, Venkatakrishnan K, Michielin O, Cuendet MA, Terranova N. Courlet P, et al. Among authors: latifyan s. CPT Pharmacometrics Syst Pharmacol. 2023 Aug;12(8):1170-1181. doi: 10.1002/psp4.12983. Epub 2023 Jun 16. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 37328961 Free PMC article.
Targeting immune checkpoints in breast cancer: an update of early results.
Solinas C, Gombos A, Latifyan S, Piccart-Gebhart M, Kok M, Buisseret L. Solinas C, et al. Among authors: latifyan s. ESMO Open. 2017 Nov 14;2(5):e000255. doi: 10.1136/esmoopen-2017-000255. eCollection 2017. ESMO Open. 2017. PMID: 29177095 Free PMC article. Review.
Immune checkpoint inhibitor-related myositis and myocarditis: diagnostic pitfalls and imaging contribution in a real-world, institutional case series.
Vicino A, Hottinger AF, Latifyan S, Boughdad S, Becce F, Prior JO, Kuntzer T, Brouland JP, Dunet V, Obeid M, Théaudin M. Vicino A, et al. Among authors: latifyan s. J Neurol. 2024 Apr;271(4):1947-1958. doi: 10.1007/s00415-023-12134-x. Epub 2023 Dec 23. J Neurol. 2024. PMID: 38141128 Free PMC article. Review.
31 results